SEC Form 4 · accession 0001144204-18-004705
Solid Biosciences Inc. · SLDB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rajeev M. Shah
Director
Period of report
Jan 30, 2018
Accepted (ET)
Jan 30, 2018 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001707502
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jan 30, 2018 | P | 1,000,000 | $16.00 | A | 2,689,444 | I | See footnotes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities include 808,990 shares held by RA Capital Healthcare Fund, L.P. (the "Fund") and 191,010 shares held in an account owned by a separately managed account (the "Account").
- F2Represents 2,177,971 shares of Common Stock held by the Fund and 511,473 shares of Common Stock held in the Account.
- F3RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Mr. Shah is a member of the Adviser. Mr. Shah has no pecuniary interest in the reported securities held in the Account and therefore disclaims beneficial ownership of those securities. Mr. Shah disclaims beneficial ownership of the reported securities held by the Fund except to the extent of his pecuniary interest therein.